NovaBridge Biosciences (NBP) Revenue (2019 - 2023)
NovaBridge Biosciences (NBP) posted quarterly Revenue of $5000.0 for Q4 2023, down 99.67% year-over-year from $1.5 million in Q4 2022, and down 98.41% quarter-over-quarter from $315000.0 in Q3 2023.
NovaBridge Biosciences (NBP) Revenue (2019 - 2023) Analysis & Trends
NovaBridge Biosciences (NBP) has reported Revenue for 4 consecutive years, with $5000.0 the latest figure, recorded in Q4 2023.
- In Q4 2023, Revenue fell 99.67% year-over-year to $5000.0; the TTM figure through Dec 2023 stood at $2.0 million (down 68.72% YoY), while the FY2023 annual figure was $632000.0, down 59.25% from the prior year.
- Revenue eased to $5000.0 in Q4 2023 per NBP's latest filing, from $315000.0 in the prior quarter.
- Across five years, Revenue topped out at $2.7 million in Q4 2020 and bottomed at $5000.0 in Q4 2023.
- Historically, Revenue has averaged $1.1 million across 4 years, with a median of $907500.0 in 2022.
- On a YoY basis, Revenue climbed as much as 99.67% in 2023 and fell as far as 99.67% in 2023.
- NovaBridge Biosciences' Revenue stood at $2.1 million in 2019, then increased by 25.51% to $2.7 million in 2020, then tumbled by 44.15% to $1.5 million in 2022, then tumbled by 99.67% to $5000.0 in 2023.
- Business Quant data shows NBP's Revenue at $5000.0 in Q4 2023, $315000.0 in Q3 2023, and $159000.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | NovaBridge Biosciences | 215.85 Mn | 215.85 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 5,000.00 |
| Sep 30, 2023 | 315,000.00 |
| Jun 30, 2023 | 159,000.00 |
| Dec 31, 2022 | 1.50 Mn |
| Dec 31, 2020 | 2.69 Mn |
| Sep 30, 2019 | 2.14 Mn |